Magnesium as an intrinsic component of human otoconia.
Level 5 - mechanism / opinion, no new human data
In vitro bench study and microstructural analysis of human and synthetic otoconia
PubMed 29764268 · doi:10.1080/00016489.2018.1467572
What was done
Researchers examined human otoconia using environmental scanning electron microscopy and energy-dispersive X-ray microanalysis (EDX) to assess magnesium content. They synthesized artificial otoconia using calcite gelatin composites (CGC) grown in vitro with magnesium substitution (Ca 1-x Mg x) or without magnesium (Ca 1 Mg 0) and compared their morphology and dimensions to natural human otoconia.
What was found
EDX and X-ray analysis demonstrated that human otoconia calcite contains minor magnesium substitution. In artificial otoconia, the presence of magnesium produced significantly smaller crystals (length 397.0 ± 146.4 µm, diameter 325.6 ± 100.1 µm) than pure CGC (length 548.6 ± 160 µm, diameter 373.0 ± 110.4 µm, p < .01). Magnesium incorporation increased the length-to-diameter ratio from 1.48 ± 0.11 in pure CGC to 1.84 ± 0.25 (p < .01), closely approximating the 1.98 ± 0.08 ratio measured in human otoconia.
Why it matters
Identifying magnesium as an intrinsic component of human otoconia explains how calcite crystal elongation is regulated during biomineralization, offering baseline structural insights relevant to otolith formation and degeneration.
Limits
The abstract does not state the sample size or source of the human otoconia analyzed. The study relies on in vitro crystallization models, which do not capture complex in vivo biological dynamics, protein interactions, or clinical vestibular disorders.
Cited by
- context Vitamin D, vitamin K2, and magnesium help alleviate vertigo by managing calcium crystal accumulation in the inner ear.